Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30127
Quantitative Structure Activity Relationship and Insilco Docking of Substituted 1,3,4-Oxadiazole Derivatives as Potential Glucosamine-6-Phosphate Synthase Inhibitors

Authors: Suman Bala, Sunil Kamboj, Vipin Saini


Quantitative Structure Activity Relationship (QSAR) analysis has been developed to relate antifungal activity of novel substituted 1,3,4-oxadiazole against Candida albicans and Aspergillus niger using computer assisted multiple regression analysis. The study has shown the better relationship between antifungal activities with respect to various descriptors established by multiple regression analysis. The analysis has shown statistically significant correlation with R2 values 0.932 and 0.782 against Candida albicans and Aspergillus niger respectively. These derivatives were further subjected to molecular docking studies to investigate the interactions between the target compounds and amino acid residues present in the active site of glucosamine-6-phosphate synthase. All the synthesized compounds have better docking score as compared to standard fluconazole. Our results could be used for the further design as well as development of optimal and potential antifungal agents.

Keywords: 1, 3, 4-Oxadiazole, QSAR, Multiple linear regression, Docking, Glucosamine-6-Phosphate Synthase.

Digital Object Identifier (DOI):

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1101


[1] S. L. Gaonkar, K. M. Rai K and B. Prabhuswamy; “Synthesis and antimicrobial studies of a new series of 2-4-
[2-(5-ethylpyridin-2-yl)ethoxy]phenyl-5-substituted-1,3,4- oxadiazoles,”European Journal of Medicinal Chemistry, vol. 41, pp. 841–846, 2006.
[2] A. Husain, M. S. Y. Khan, S. M. Hasanand M. M. Alam; “2-Arylidene-4- (4- phenoxyphenyl)but-3-en-4-olides: Synthesis, reactions and biological activity,” European Journal of Medicinal Chemistry, vol. 40, pp. 1394–1404, 2005.
[3] F. A. Omar, N. M. Mahfouz and M. A. Rahman; “Design, synthesis and anti-inflammatory activity of some 1,3,4-oxadiazole derivatives,” European Journal of Medicinal Chemistry, Vol. 31, pp. 819-825, 1996.
[4] B. Narayana, K. K. Vijayaraj, B. V. Ashlatha and N. S. Kumari; “Synthesis of some new 2-(6-methoxy-2-naphthyl)-5-aryl-1,3,4-oxadiazoles as possible non-steroidal anti-inflammatory and analgesic agents,” Archiv der Pharmazie, vol.338, pp. 373–377, 2005.
[5] T. M. Tan, Y Chen, K. H. Kong, J. Bai, Y. Li, S. G. Lim, T. H. Ang and Y. Lam; “Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl- (1,3,4) oxadiazoles as potential anti-hepatitis B virus agents,” Antiviral Research, vol. 71, pp.7–14, 2006.
[6] M. Amir and S. Kumar; “Synthesis and evaluation of anti- inflammatory, analgesic and lipid
[7] peroxidation properties of ibuprofen derivatives,” Acta Pharmaceutica, vol. 57, pp. 31–45, 2007.
[8] M. A. Ali and M. S. Yar; “Oxadiazole Mannich bases: Synthesis and antimycobacterial activity,” Bioorganic and Medicinal Chemistry Letters, vol.17, pp. 3314–3316, 2007.
[9] A. Zarghi, S. A. Tabatabai, M. Faizi, A. Ahadian, P. Navabi, V. Zanganeh and A. Shafiee; “Synthesis and anticonvulsant activity of new 2-substituted- 5-(2-benzyloxyphenyl)-1,3,4-oxadiazole,” Bioorganic and Medicinal Chemistry Letters, vol. 15, pp.1863–1865, 2005.
[10] M. Wojciechowski, S. Milewski, J. Mazerskiand E. Borowski; “Glucosamine-6-phosphate synthase, a novel target for antifungal agents- Molecular modelling studies in drug design,” Acta Biochemica Polonica, vol. 52, pp. 647–653, 2005.
[11] A. Teplyakov, G. Obmolova, M. A. Badet-Denisot, B. Bade; “Channeling of ammonia in glucosamine-6-phosphate synthase,” Journal of Molecular Biology, vol, 313, pp. 1093– 1102, 2001.
[12] M. N. Isupov, G. Obmolova, S. Buerworth, M. A. Badet-Denisot, B. Badet, I. Polikarpov, J. A. Littlechild, A. Teplyakov; “Substrate binding is required for assembly of the active conformation of the catalytic site in Ntnamidotransferases: Evidence from the 1.8 Å crystal structure of the glutaminase domain of glucosamine 6-phosphate synthase,” Structure, vol. 4, pp. 801–810, 1996.
[13] E. Borowski; “Novel approaches in the rational design of antifungal agents of low toxicity,” Farmaco, vol.55, pp. 206–208, 2000.
[14] H. Komatsuzawa, T. Fujiwara, H. Nishi, S. Yamada, M. Ohara, N. McCallum, B. Berger-Bachi, M. Sugai; “The gate controlling cell wall synthesis in Staphylococcus aureus,” Molecular Microbiology, vol. 53, pp. 1221, 2004.
[15] H. Chmara, R. Andruszkiewicz, E. Borowski; “Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT2 by fumaroyldiaminopropanoic acid derivatives, a novel group of glutamine analogs,” Biochimica et Biophysica Acta, vol. 870, pp. 357–366, 1986.
[16] B. Badet, P. Vermoote, F. Goffic; “Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives,” Biochemistry, vol. 27, pp. 2282–2287, 1998.
[17] W. S. Han, J. K. Lee, J. S. Lee, H. Hahn, and C. N. Yoon; Study of Thiazoline Derivatives for the Design of Optimal Fungicidal Compounds Using Multiple Linear Regressions (MLR),” Bulletin of Korean Chemical Society, vol. 33, pp. 1703-1706, 2012.
[18] U. D. Patil, A. P. Nikum, P. S. Nagle and P. P. Mahulikar; “Synthesis, Antimicrobial and Antifungal Activity Evaluation of 2,6-Diaryl-4-Sec-Aminonicotinonitriles and 4-Sec-Amino-6-Aryl-2-(Pyridinyl)Pyridine-3-Carbonitriles i.e. Bipyridines and Their Docking Study,” Journal of Pharmacy Research, vol. 5(3):1383-1386, 2012.
[19] M. H. Christensen; “MolDock: A New Technique for High-Accuracy Molecular Docking,” Journal of Medicinal Chemistry, vol. 49, issue 11, pp. 3315 – 3321, 2006.
[20] S. Borkotoky; “Docking Studies on HIV Integrase Inhibitors Based On Potential Ligand Binding Sites,” International Journal on Bioinformatics and Biosciences. vol. 2, pp. 21-29,2012.
[21] A. Leo, C. Hansch, D. Elkins; “Partition coefficients and their uses,” Chemical Reviews, vol. 71, no. 6, pp. 525–616, 1971.
[22] A. Momen-Roknabadi, M. Sadeghi, H. Pezeshk, S. A. Marashi; “Impact of residue accessible surface area on the prediction of protein secondary structures,” Bioinformatics, vol. 9, pp. 357, 2008.
[23] R. Adamczak, A. Porollo, J. Meller; “Combining prediction of secondary structure and solvent accessibility in proteins,” Proteins, vol. 59, no. 3, pp.467 -75, 2005.
[24] B. Max B and E. Wolf; “Principles of optics: Electromagnetic theory of propagation, interference and diffraction of light,” Cambridge University Press, 7th edt. Section 2.3.3, 1999.
[25] D. P. Kawade, P. B. Khedekar, K. P. Bhusari; “QSAR studies of 6-aminopyrimidin-4-one derivatives as antiinflammatory agent,” International Journal of Pharmaceutical and Biomedical Research, vol. 2, no. 1, pp. 13-16, 2011.
[26] M. L. Connolly; “Solvent-accessible surface of proteins and nucleic acids,” Science, vol. 221, pp. 709-713, 2010.
[27] M. E. Weiser; “Atomic weights of elements,” Pure Applied Chemistry, vol. 78: pp. 2051, 2005.
[28] A. Teplyakov, G. Obmolova, M. Badet-Denisot, and B. Badet; “The mechanism of sugar phosphate isomerization by glucosamine 6-phosphate synthase,” Protein Science, vol. 8, pp. 596–602,1999.